Coxibs were not cost effective for arthritis pain in patients with average risk of ulcer complicationsThe cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis.

Laine, Loren MD (commentator)
Spiegel, BM
Targownik, L
Dulai, GS
et al,

University of Southern California Los Angeles, California, USA

Spiegel BM, Targownik L, Dulai GS, et al. The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis. Ann Intern Med 2003;138:795–806SpiegelBMTargownikLDulaiGSet alThe cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis.Ann Intern Med2003138795-806

Sources of funding: National Institutes of Health and Veterans Administration.

For correspondence: Dr I M Gralnek, Veterans Administration Greater Los Angeles Healthcare System, Los Angeles, CA, USA. [email protected]

Abstract and commentary also appear in ACP Journal Club.

Evidence Based Medicine 8(5):p 159, September-October 2003.